Photodynamic therapy (PDT) involves the interaction between a photosensitiz
ing agent and light, in the presence of oxygen, to produce photodamage to t
arget tissue, While photodynamic therapy has been used since ancient times
to treat dermatoses, it was not until the 1960s that porphyrin-based photos
ensitizers were first used for photodetection and phototherapy of malignanc
ies, Thereafter, clinical experience accumulated slowly until the mid-1990s
, when regulatory approval for PDT using porfimer sodium was granted in par
ts of North America, Europe, and Japan. This paper reviews recent clinical
advances and discusses technological developments that may soon alter the w
ay in which photodynamic therapy is used.